Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Time to Onset of sCTX Suppression with Monthly Ibandronate in Postmenopausal Osteoporosis
NCT00303485Phase 4Completed
- Sponsor
- Roche
- Start
- Feb 2006
- Primary completion
- Jun 2007
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of ibandronate in postmenopausal osteoporosis, sponsored by Roche. Started Feb 2006; status: completed.
02
Drugs
ibandronate
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on NCT00303485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00303485.